On July 25th, the Longgang District Enterprise Service Conference was grandly held at Shenzhen Information Vocational and Technical University. The highly anticipated " 100 Emerging Enterprises in Longgang District" list was announced at the conference, and Shenzhen Sungening Biotechnology Co., Ltd. was honored to be listed with outstanding achievements and strong development potential in the field of innovative drugs, becoming an important representative of the development of emerging industries in Longgang District.
As a rising force in the field of innovative drugs, Sungening Biotechnology has adhered to the corporate vision of "focusing on the research and development of new drugs that meet clinical needs and protect human health" since its establishment. The company focuses on the forefront of innovative drug research and development, forming a research and development team led by high-level talents at home and abroad, overcoming multiple technical difficulties in the fields of antifungal and metabolic lipid-lowering, and continuously injecting new momentum into the industry's development.
This selection as one of the "Top 100 Emerging Enterprises in Longgang District" is not only a high recognition of Sungening Biotechnology's innovation strength, but also a full affirmation of its contribution to promoting the upgrading of the biotechnology industry and supporting the high-quality development of the regional economy. Looking ahead to the future, Sungening Biotechnology will continue to increase research and development investment, deepen the integration of industry, academia, and research, accelerate the transformation of technological achievements, and strive to achieve more breakthroughs in the field of innovative drugs. The company will surely shoulder the honor and mission of being one of the "Top 100 Emerging Enterprises", and contribute more "Sungening Power" to the construction of the "3+4+N+AI" industrial system and innovative urban area in Longgang District!
Longgang District Enterprise Service Conference Site (2025)
